India Animal Vaccines Market Overview
As per MRFR analysis, the India Animal Vaccines Market Size was estimated at 238 (USD Million) in 2023.The India Animal Vaccines Market is expected to grow from 248.4(USD Million) in 2024 to 496.8 (USD Million) by 2035. The India Animal Vaccines Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).
Key India Animal Vaccines Market Trends Highlighted
Various elements are driving notable expansion in the India Animal Vaccines Market. Increasing knowledge among livestock producers about the need for animal health and preventative actions is one of the main market drivers as it helps to guarantee food safety and security. Especially with the drive toward improving the dairy and poultry industries, the government of India has been aggressively supporting vaccination campaigns for animals to fight illnesses that can affect livestock production. High-quality animal products are also in more customer demand, which drives farmers to use vaccines to enhance the general health of their animals.
The growing livestock sector offers great possibilities in the India Animal Vaccines Market. Government efforts to strengthen animal husbandry by means of research and development of novel vaccinations help to provide a good environment for businesses to manufacture and introduce successful goods. Furthermore, as urbanization develops, there is more possibility for companion animal immunizations, a category that has grown in recent years. The importance of zoonotic diseases and their effect on public health underlines even more the necessity of strong vaccination policies, which pave the way for further government and private sector cooperation.
Recent developments in the India Animal Vaccines Market reveal a move toward more sophisticated and efficient vaccine formulations, including recombinant vaccines and thermostable choices that can preserve effectiveness under various environmental circumstances. Vaccine research is being driven by biotechnology, which is opening the door for creative answers addressing both conventional and new illnesses. Furthermore, the increased usage of digital technology in veterinary healthcare is providing improved vaccine monitoring and management, ensuring that vaccination regimens are followed and helping farmers maximize their livestock health practices. The India Animal Vaccines Market is changing with a sharp eye on creativity, health awareness, and improved stakeholder cooperation.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Animal Vaccines Market Drivers
Rising Livestock Population in India
The India Animal Vaccines Market Industry is experiencing significant growth due to the increasing livestock population. According to the 20th Livestock Census conducted by the Government of India, the country's livestock population reached over 535 million in 2019, representing a 4.6% increase since the previous census. This growing population creates a rising demand for animal vaccines to ensure the health and productivity of these animals.ย
Organizations such as the Indian Council of Agricultural Research (ICAR) are emphasizing the need for increased vaccination programs to control diseases among livestock.With diseases such as Foot-and-Mouth Disease and Brucellosis posing risks to animal health and agricultural productivity, the expansion of vaccination initiatives is essential, thereby propelling the India Animal Vaccines Market Industry.
Government Initiatives for Animal Health
The Indian government has prioritized animal health and disease management, which is a significant driver for the India Animal Vaccines Market Industry. Programs like the National Animal Disease Control Programme aim to vaccinate a significant portion of the livestock population against major diseases, targeting to immunize over 500 million livestock units. The allocation of substantial financial resources for vaccination campaigns and veterinary services enhances the development and availability of animal vaccines, resulting in increased market growth.
Institutions such as the Department of Animal Husbandry and Dairying have been pivotal in promoting vaccination awareness and campaigns across rural areas, strengthening the overall animal health infrastructure.
Technological Advancements in Vaccine Development
Technological innovations in vaccine development are crucial in the India Animal Vaccines Market Industry's growth trajectory. The development of advanced vaccines, such as subunit vaccines and mRNA vaccines, promises effective disease control and improved safety for animals. According to the Ministry of Science and Technology, several laboratories and research institutions are focused on Research and Development (R&D) to develop next-generation vaccines that are more effective and easier to administer.
The introduction of these new technologies positions the Indian veterinary market to address both current and emerging health challenges efficiently, driving substantial growth in the animal vaccines sector.
India Animal Vaccines Market Segment Insights
Animal Vaccines Market Technology Insights
The India Animal Vaccines Market, particularly within the Technology segment, is experiencing significant advancements driven by various vaccine types that cater to a wide range of animal health needs. Inactivated Vaccines are recognized for their robustness, often considered the gold standard for immune response in animals, making them a popular choice among veterinarians and livestock owners. Meanwhile, Attenuated Vaccines, known for activating a strong and quick immune response, hold substantial importance in preventing contagious diseases among livestock, particularly in densely populated animal farming regions in India.Subunit Vaccines, which use only specific parts of the pathogen, are gaining traction due to their safety profile and the potential for targeted immunity, thus minimizing unwanted reactions.ย
This technology is especially relevant in urban and semi-urban settings where pet ownership is surging. On the other hand, DNA Vaccines are emerging as a cutting-edge alternative, offering benefits such as stability and ease of production, which resonates well with the growing demand for rapid vaccine development in India as zoonotic diseases become more prevalent.mRNA Vaccines, although traditionally associated with human health, are beginning to capture interest in the animal health sector as advancements in biotech enable their development for veterinary applications. With the rise of genomic technology, these types of vaccines present an exciting opportunity to mitigate disease threats and improve animal health outcomes by harnessing the body's natural immune response. The overall dynamics of the Technology segment within the India Animal Vaccines Market indicate a move towards innovation and modernization, driven by the increasing need for effective disease management strategies in both livestock and companion animals.ย
Furthermore, government initiatives in India focusing on strengthening the agricultural sector, alongside the growing population and increased meat consumption, establish a favorable environment for the evolution of these technologies. This sustained focus on animal health has spurred Research and Development efforts, particularly in vaccine technology, thereby enhancing the capacity for tackling animal diseases in a more efficient manner. Overall, the Technology segment within the India Animal Vaccines Market showcases a landscape ripe with potential for growth, driven by scientific progress and the pressing need for enhancing animal health.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Vaccines Market Animal Type Insights
The India Animal Vaccines Market segmentation based on Animal Type shows significant diversity among its categories, each contributing uniquely to the overall landscape. Pets, including dogs and cats, are gaining popularity in urban areas, driving the demand for innovative vaccines to protect against diseases. Livestock, which comprises cattle, sheep, and goats, represents a substantial portion of the market due to the countryโs reliance on agriculture and dairy production. Consequently, there is a continuous need for effective vaccination to enhance productivity and safeguard farmers' livelihoods.The poultry sector remains vital, as India ranks among the largest producers of eggs and chicken meat, warranting robust vaccination programs to combat prevalent diseases.ย
Wildlife vaccines are becoming increasingly crucial, especially in protecting endangered species and containing zoonotic diseases that affect human populations. Aquaculture is witnessing growth as well, given the rising demand for fish and seafood, necessitating vaccines to ensure the health of aquatic species. Overall, each category under the Animal Type segment of the India Animal Vaccines Market reflects the interplay of economic factors and public health considerations, highlighting the market's potential trajectory and growth opportunities.
Animal Vaccines Market Route of Administration Insights
The India Animal Vaccines Market, particularly within the Route of Administration segment, showcases a diverse range of delivery methods critical for ensuring effective immunization across various animal species. Injectable vaccines continue to lead in popularity due to their reliability and fast-acting responses, making them essential for rapid disease control. Oral vaccines play a significant role in increasing compliance among animal owners, particularly in livestock, as they are easy to administer. Intranasal vaccines are gaining traction, particularly for respiratory illnesses, due to their non-invasive nature and ability to elicit strong mucosal immunity.
Meanwhile, topical applications are becoming increasingly relevant, especially for certain types of diseases that require localized treatment. This diversity in routes supports the unique needs of the veterinary field in India, addressing factors such as ease of use, target animal species, and specific disease challenges prevalent in the region. As the veterinary landscape evolves, the demand for varied administration methods reflects the ongoing commitment to improving animal health and productivity, aligning with the national focus on agricultural stability and food security.
Animal Vaccines Market Distribution Channel Insights
The Distribution Channel segment of the India Animal Vaccines Market plays a crucial role in ensuring the availability and accessibility of vaccines across various platforms. Veterinary Clinics serve as primary points for the administration and recommendation of vaccines, underscoring their significance in disease prevention among domestic animals. Retail Pharmacies offer convenience for pet owners seeking over-the-counter vaccination solutions, contributing to the market's growth by increasing consumer reach. Meanwhile, Online Pharmacies have gained traction, particularly amidst the digital shift in healthcare, allowing consumers to easily procure vaccines without geographical constraints.Animal Hospitals, equipped with veterinary specialists, are essential for administering complex vaccinations and managing animal health comprehensively.ย
This diversified distribution approach is vital for addressing varying consumer preferences and enhancing the overall efficiency of vaccination programs in India. The market dynamics reflect a trend toward holistic access to vaccines, ensuring that critical immunizations are delivered effectively to safeguard animal health and support livestock productivity in a growing agricultural economy. Moreover, the rising awareness of animal health and welfare in India fuels the demand across all distribution avenues, highlighting the importance of an integrated and responsive distribution network in the animal healthcare ecosystem.
India Animal Vaccines Market Key Players and Competitive Insights
The competitive landscape of the India Animal Vaccines Market is characterized by a mix of domestic and international players striving to gain a foothold in a region witnessing substantial growth due to increasing livestock populations and the rising awareness of disease management among animal husbandry professionals. As this market expands, companies focus on developing innovative and effective vaccine solutions to address various infectious diseases that affect livestock and companion animals alike. The increasing demand for protein-rich food and the rising incidence of zoonotic diseases are propelling market dynamics, thus encouraging manufacturers to enhance their production capabilities and improve their distribution networks.ย
Collaboration with veterinary practitioners and educational institutions further strengthens their market positioning as they push for advancements in preventive healthcare for animals.Equine Biotech has established a significant presence in the India Animal Vaccines Market with an emphasis on high-quality vaccines and innovative health solutions for equine and livestock. The company capitalizes on an extensive research and development framework that allows it to stay ahead in the competitive race by introducing advanced vaccine formulations tailored specifically for Indian livestock needs. The strengths of Equine Biotech lie in its dedicated customer support, substantial investment in local manufacturing, and robust distribution channels that cater to rural and urban veterinary needs. By focusing on building long-term relationships with veterinarians and livestock farmers, Equine Biotech effectively enhances its brand presence and market share within the region.
Vetoquinol, a renowned player in the global animal health sector, is making significant strides in the India Animal Vaccines Market through its strong portfolio of vaccines and treatments. The company's key offerings include vaccines for various diseases affecting both large and small animals, emphasizing efficacy and safety. With a well-established market presence in India, Vetoquinol takes advantage of strict regulatory compliance and partnerships with local stakeholders to ensure its products meet the needs of Indian veterinarians and farmers. Strengths include innovative product development, a wide range of veterinary pharmaceuticals, and strategic mergers that have bolstered their market position. Their commitment to research and development is evident as they consistently invest in formulating new solutions that address emerging health challenges within the Indian animal population.
Key Companies in the India Animal Vaccines Market Include:
- Equine Biotech
- Vetoquinol
- Aventis Pharma
- India Immunologicals
- Virbac
- Zoetis
- Merck Animal Health
- Elanco Animal Health
- Boehringer Ingelheim
- Hester Biosciences
- Nectar Life Sciences
- Ind Swift Laboratories
- Prawn Biotechnology
- Biovet
- Cadila Healthcare
India Animal Vaccines Market Industry Developments
The India Animal Vaccines Market has witnessed significant developments recently, notably with an increasing focus on disease prevention and control among livestock, leading to strong demand for effective vaccines. Companies such as Zoetis, Merck Animal Health, and Hester Biosciences are actively working on innovative vaccine solutions to address the surge in zoonotic diseases. In September 2023, Boehringer Ingelheim announced advancements in their veterinary vaccines that bolster protection against multiple pathogens affecting cattle and poultry, further enhancing their market presence.ย
Additionally, in July 2023, Vetoquinol reported new partnerships with local veterinary networks to expand their distribution channels across India, influencing growth rates in the sector. In terms of mergers and acquisitions, India Immunologicals revealed plans for acquiring a smaller firm in August 2023 aimed at enhancing their production capabilities, bolstering their position in the vaccine market. The market is projected to experience significant growth, with a reported valuation expected to reach USD 2 billion by 2025, driven by an increase in livestock populations and heightened awareness regarding animal health in the country.
India Animal Vaccines Market Segmentation Insights
-
Animal Vaccines Market Technology Outlook
- Inactivated Vaccines
- Attenuated Vaccines
- Subunit Vaccines
- DNA Vaccines
- mRNA Vaccines
-
Animal Vaccines Market Animal Type Outlook
- Pets
- Livestock
- Poultry
- Wildlife
- Aquaculture
-
Animal Vaccines Market Route of Administration Outlook
- Injectable
- Oral
- Intranasal
- Topical
-
Animal Vaccines Market Distribution Channel Outlook
- Veterinary Clinics
- Retail Pharmacies
- Online Pharmacies
- Animal Hospitals
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
238.0(USD Million) |
MARKET SIZE 2024 |
248.4(USD Million) |
MARKET SIZE 2035 |
496.8(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
6.504% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Equine Biotech, Vetoquinol, Aventis Pharma, India Immunologicals, Virbac, Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, Hester Biosciences, Nectar Life Sciences, Ind Swift Laboratories, Prawn Biotechnology, Biovet, Cadila Healthcare |
SEGMENTS COVERED |
Technology, Animal Type, Route of Administration, Distribution Channel |
KEY MARKET OPPORTUNITIES |
Increasing livestock population, Rising demand for pet vaccines, Government livestock health initiatives, Growth in animal husbandry practices, Advancements in vaccine technology |
KEY MARKET DYNAMICS |
Rising demand for livestock health, Government initiatives and funding, Increasing prevalence of zoonotic diseases, Growing awareness of animal welfare, Advancements in vaccine technologies |
COUNTRIES COVERED |
India |
Frequently Asked Questions (FAQ) :
The India Animal Vaccines Market is expected to be valued at 248.4 million USD in 2024.
By 2035, the India Animal Vaccines Market is projected to reach 496.8 million USD.
The expected CAGR for the India Animal Vaccines Market from 2025 to 2035 is 6.504%.
The Inactivated Vaccines segment is expected to lead the market with a value of 110.6 million USD in 2024.
The Attenuated Vaccines segment is valued at 62.0 million USD in 2024 and is expected to reach 124.0 million USD by 2035.
Major players in the market include Zoetis, Merck Animal Health, and Boehringer Ingelheim among others.
The Subunit Vaccines segment is expected to be valued at 72.4 million USD by 2035.
Opportunities include advancing vaccine technologies and increasing awareness about animal health.
The mRNA Vaccines segment is anticipated to reach 46.2 million USD by 2035.
Challenges include regulatory hurdles and competition from alternative treatment options.